Philip J. Bergman

8.6k total citations · 1 hit paper
113 papers, 5.2k citations indexed

About

Philip J. Bergman is a scholar working on Pulmonary and Respiratory Medicine, Small Animals and Surgery. According to data from OpenAlex, Philip J. Bergman has authored 113 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 37 papers in Small Animals and 22 papers in Surgery. Recurrent topics in Philip J. Bergman's work include Veterinary Oncology Research (64 papers), Infectious Diseases and Mycology (19 papers) and Virus-based gene therapy research (19 papers). Philip J. Bergman is often cited by papers focused on Veterinary Oncology Research (64 papers), Infectious Diseases and Mycology (19 papers) and Virus-based gene therapy research (19 papers). Philip J. Bergman collaborates with scholars based in United States, United Kingdom and Canada. Philip J. Bergman's co-authors include Leon O. Murphy, Beat Nyfeler, Christopher J. Wilson, Peter M. Finan, Ellen Triantafellow, D. Craft, Haidi Yang, Marc Hild, Jeffrey P. MacKeigan and Vic E. Myer and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Philip J. Bergman

110 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy

2009 1.4k citations Philip J. Bergman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip J. Bergman United States	34	2.2k	1.7k	1.1k	1.0k	855	113	5.2k
Joshua D. Webster United States	36	1.0k 0.5×	2.7k 1.6×	575 0.5×	1.5k 1.5×	293 0.3×	76	4.7k
Tsutomu Katsuyama Japan	45	1.7k 0.7×	2.9k 1.7×	512 0.5×	1.8k 1.8×	425 0.5×	239	7.3k
Oliver A. Garden United Kingdom	29	529 0.2×	888 0.5×	253 0.2×	1.2k 1.2×	293 0.3×	102	3.1k
Hang Yuan United States	29	756 0.3×	2.1k 1.2×	99 0.1×	419 0.4×	469 0.5×	82	4.0k
I. J. D. Lindley Austria	37	490 0.2×	1.0k 0.6×	377 0.4×	2.8k 2.7×	344 0.4×	84	5.4k
Yoshinobu Eishi Japan	39	1.8k 0.8×	2.2k 1.3×	107 0.1×	641 0.6×	302 0.4×	252	7.8k
Nicole Porchet France	48	970 0.4×	4.6k 2.7×	81 0.1×	1.4k 1.3×	639 0.7×	138	7.0k
David Allman United States	57	468 0.2×	3.3k 2.0×	209 0.2×	6.7k 6.6×	652 0.8×	112	11.0k
Brenda L. Coomber Canada	31	472 0.2×	1.9k 1.1×	177 0.2×	341 0.3×	209 0.2×	87	3.6k
Gale A. Granger United States	34	330 0.1×	1.5k 0.9×	166 0.2×	3.4k 3.3×	311 0.4×	156	5.4k

Countries citing papers authored by Philip J. Bergman

Since Specialization

Citations

This map shows the geographic impact of Philip J. Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Bergman more than expected).

Fields of papers citing papers by Philip J. Bergman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Bergman. The network helps show where Philip J. Bergman may publish in the future.

Co-authorship network of co-authors of Philip J. Bergman

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Bergman. A scholar is included among the top collaborators of Philip J. Bergman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Bergman. Philip J. Bergman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergman, Philip J.. (2023). Cancer Immunotherapy. Veterinary Clinics of North America Small Animal Practice. 54(3). 441–468. 9 indexed citations

Buote, Nicole J., et al.. (2022). Medicinal Leech Therapy in Veterinary Medicine: A Retrospective Study. Journal of the American Animal Hospital Association. 58(6). 303–308.

Boston, Sarah E., Owen T. Skinner, James A. Perry, et al.. (2021). Survival time of juvenile dogs with oral squamous cell carcinoma treated with surgery alone: A Veterinary Society of Surgical Oncology retrospective study. Veterinary Surgery. 50(4). 740–747. 7 indexed citations

Weishaar, Kristen, Mona P. Rosenberg, Gerald Post, et al.. (2021). Multicenter, randomized, double-blinded, placebo-controlled study of rabacfosadine in dogs with lymphoma. Journal of Veterinary Internal Medicine. 36(1). 215–226. 8 indexed citations

Mullin, Christine, et al.. (2021). Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy. PubMed Central. 62(2). 133–140. 3 indexed citations

Meleo, Karri A., Gerald Post, Craig A. Clifford, et al.. (2020). Concurrent use of rabacfosadine and L-asparaginase for relapsed or refractory multicentric lymphoma in dogs. Journal of Veterinary Internal Medicine. 34(2). 882–889. 8 indexed citations

Leibman, Nicole F., et al.. (2020). Prognostic Indicators and Clinical Outcome in Dogs with Subcutaneous Mast Cell Tumors Treated with Surgery Alone: 43 Cases. Journal of the American Animal Hospital Association. 56(4). 215–225. 23 indexed citations

Dmitriev, Igor P., Elena A. Kashentseva, Jeffrey N. Bryan, et al.. (2016). A One Health overview, facilitating advances in comparative medicine and translational research. Clinical and Translational Medicine. 5(S1). 17 indexed citations

Bonczynski, Jennifer J., et al.. (2016). Perioperative Cefovecin to Reduce the Incidence of Urinary Tract Infection in Dogs Undergoing Hemilaminectomy. Journal of the American Animal Hospital Association. 52(5). 297–304. 8 indexed citations

10.

Kitchell, Barbara E., et al.. (2015). Safety of administering the canine melanoma DNA vaccine (Oncept) to cats with malignant melanoma – a retrospective study. Journal of Feline Medicine and Surgery. 19(2). 224–230. 21 indexed citations

11.

Manley, Christina, Nicole F. Leibman, J. D. Wolchok, et al.. (2010). Xenogeneic Murine Tyrosinase DNA Vaccine for Malignant Melanoma of the Digit of Dogs. Journal of Veterinary Internal Medicine. 25(1). 94–99. 49 indexed citations

12.

London, Cheryl A., Phyllis B. Malpas, Stacey L. Wood-Follis, et al.. (2009). Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision. Clinical Cancer Research. 15(11). 3856–3865. 295 indexed citations

13.

Bonczynski, Jennifer J., et al.. (2008). Retrospective Evaluation of Lingual Tumors in 42 Dogs: 1999–2005. Journal of the American Animal Hospital Association. 44(6). 308–319. 18 indexed citations

14.

Gieger, Tracy L., Kenneth M. Rassnick, David R. Proulx, et al.. (2008). Palliation of Clinical Signs in 48 Dogs With Nasal Carcinomas Treated With Coarse-fraction Radiation Therapy. Journal of the American Animal Hospital Association. 44(3). 116–123. 30 indexed citations

15.

Mealey, Katrina L., Janean L. Fidel, John Gay, et al.. (2008). ABCB1-1Δ Polymorphism Can Predict Hematologic Toxicity in Dogs Treated with Vincristine. Journal of Veterinary Internal Medicine. 22(4). 996–1000. 33 indexed citations

16.

Bergman, Philip J., Maura G. O’Brien, J. A. McKnight, et al.. (2006). Retrospective Evaluation of Adjunctive Doxorubicin for the Treatment of Feline Mammary Gland Adenocarcinoma: 67 Cases. Journal of the American Animal Hospital Association. 42(2). 110–120. 42 indexed citations

17.

Ludwig, Lori, et al.. (2005). Feline Cutaneous Hemangiosarcoma: A Retrospective Study of 18 Cases (1998–2003). Journal of the American Animal Hospital Association. 41(2). 110–116. 21 indexed citations

18.

Bergman, Philip J., et al.. (2005). Laryngeal, Laryngotracheal, and Tracheal Masses in Cats: 27 Cases (1998–2003). Journal of the American Animal Hospital Association. 41(5). 310–316. 42 indexed citations

19.

Bergman, Philip J.. (1998). Etiology of feline vaccine-associated sarcomas: history and update. Journal of the American Veterinary Medical Association. 213(10). 1424–1425. 8 indexed citations

20.

Bergman, Philip J., Stephen J. Withrow, Rodney C. Straw, & Barbara E. Powers. (1994). Infiltrative lipoma in dogs: 16 cases (1981–1992). Journal of the American Veterinary Medical Association. 205(2). 322–324. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact